Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis: a Prospective, Randomized, Double-blind, Placebo-controlled Trial

NCT04123405 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT04123405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04123405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis: a Prospective, Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Sandoz
Phase
Phase 3
Overall status
Completed
Start date
October 22, 2020
Completion date
April 20, 2021
Enrollment
944 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

rhinosinusitis